focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
?
Ten days ago Graphene and Steve Hodge were featured on the above. This weeks edition featured a super lightweight bicycle frame in graphene and the designer who also implanted graphene circuits that monitored the responses in the frame and adjusted the frame for best efficiency.
Anybody else see it, worth a catchup if you can do catchup on your TV.
strudel. Take it easy. 4000 ft to cold for me, happy at 500 ft here in Brum.
Yes Sock you had me wondering who you responded to.
As for comments on blood flow and why people are not made more aware?
If FF were a drug, the drug companies would be all over it and maybe then the price would be lower.
Difficult to convince peeps of FF when the price is what it is and the advertising would be a sinkhole for a companys money.
Over to DSM again and their marketing machine, PXS don't have the budget..
Colbalt.
Not sure I am qualified enough to respond as well as others might, but will do my best.
Not sure how the presiding is a factor. PXS are a company of 2 heads that were 3, just maintaining the IP and documentation. The company have never been in a position to take FF forward as a product, it would have cost millions upon millions. Hence the arrival of DSM who have the plant and resources. Be thankful PXS still have the IP, without it PXS would have gone 5 years ago or more.
The end user is with DSM, they have the marketing resources.
The remuneration packages have no bearing on the SP IMO.
Deadlines are up to DSM nowadays, perhaps PXS should have been more circumspect here.
Lack of vision and enthusiasm. Well don’t understand that comment at all.
Final observations from me, is, that loads of investors realise the potential here but many of us thought it would happen way back when. The reason we hang on is the potential. I was persuaded all those years ago by asshur and his enthusiasm when I was an infant investor.
Remember you can sell and invest somewhere else anytime, your decision. You could get some money back elsewhere. VRS?
Gostoso. Just out of interest? How are the BOD useless and let you down?
Quote from last RNS. Not sure if it helps?
The Company is pleased to announce the appointments of Dr Denis Koltsov and Dr Martin Kemp to strengthen its graphene technology team, with a particular focus on quality assurance. Both Dr Kemp and Dr Kolsov are at the forefront of developing the international standards that will define graphene and other nanomaterials.
Dr Denis Koltsov is Chair of ISO TC 229 Nanotechnology Standards Group at ISO (International Organization for Standardization). ISO TC 229 has already published 65 ISO standards in the field of nanotechnologies and has a further 43 standards under development. Their focus is on developing a set of peer reviewed standards for graphene and closely related materials that will facilitate the ability of producers and users of these materials to have confidence in the level of performance on a consistent and measurable basis.
Sorry, could not be bothered to digest all that post.
What relevance does it have to FF ?